Skip to content

ALBECESA

Active
Private limited companyfounded 20188 yrs activeWinston Churchilllaan 3, 1180 Ukkel, BelgiumKBO/BCE: BE 0698.570.838
Summary

ALBECESA has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €188,097 and a net result of €116,174. Equity is growing by ~26.8% per year across the filed fiscal years. Its solvency ranks better than 71% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100▲+25
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18,000 at 30 days acceptable
Liquidity ample (current ratio 5.46 against 17.86 in 2024; short-term debt: 18.2% and cash: 73.6% of total assets), and 18.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
81.6%
Return on assets
50.4%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-05-2026, 73 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
73 d early
2024
58 d early
2023
36 d early
2022
39 d early
2021
25 d early
2020
52 d early
2019
58 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 49 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 22 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 19 June 2018, ALBECESA was incorporated.1 Total assets went from EUR 95,752 in 2018 to EUR 230,568 in 2025 and headcount from 0.8 full-time equivalents in 2023 to 1 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018, 2023 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€188,097▲ 83.2%
2024 · €102,673
Total assets
€230,568▲ 108%
2024 · €111,053
Net result
€116,174▲ 8.2%
2024 · €107,359
Working capital
€187,664▲ 81.6%
2024 · €103,365
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€74,272▲ 76.2%€109,577▲ 47.5%-€50,567€162,344€152,640▼ 6.0%
Net result-€9below the sector's middle half€37,082within the sector's middle half-€123,374below the sector's middle half€107,359within the sector's middle half€116,174within the sector's middle half▲ 8.2%
Equity€81,677within the sector's middle half=€118,759within the sector's middle half▲ 45.4%-€4,686below the sector's middle half€102,673within the sector's middle half€188,097within the sector's middle half▲ 83.2%
Total assets€106,993below the sector's middle half▲ 10.6%€162,851within the sector's middle half▲ 52.2%€28,606below the sector's middle half▼ 82.4%€111,053below the sector's middle half▲ 288%€230,568within the sector's middle half▲ 108%
Debt€25,316▲ 67.8%€44,092▲ 74.2%€33,292▼ 24.5%€8,380▼ 74.8%€42,470▲ 407%
Working capital€82,550within the sector's middle half▼ 0.3%€131,593within the sector's middle half▲ 59.4%-€5,671below the sector's middle half€103,365within the sector's middle half€187,664within the sector's middle half▲ 81.6%
Solvency76.3%within the sector's middle half▼ 8.1pp72.9%within the sector's middle half▼ 3.4pp-16.4%below the sector's middle half▼ 89.3pp92.5%above the sector's middle half▲ 108.8pp81.6%within the sector's middle half▼ 10.9pp
Current ratio4.61within the sector's middle half▼ 2.825.67within the sector's middle half▲ 1.060.82below the sector's middle half▼ 4.8517.86above the sector's middle half▲ 17.045.46within the sector's middle half▼ 12.40
Return on assets (ROA)0.0%below the sector's middle half▼ 31.3pp22.8%within the sector's middle half▲ 22.8pp-431.3%below the sector's middle half▼ 454.1pp96.7%above the sector's middle half▲ 528.0pp50.4%above the sector's middle half▼ 46.3pp
Staff (FTE)0.81▲ 25.0%1=
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€200,000-€100,000€0€100,000€200,000Operating result 2021: €74,272€74,272Net result 2021: -€9-€9Operating result 2022: €109,577€109,577Net result 2022: €37,082€37,082Operating result 2023: -€50,567-€50,567Net result 2023: -€123,374-€123,374Operating result 2024: €162,344€162,344Net result 2024: €107,359€107,359Operating result 2025: €152,640€152,640Net result 2025: €116,174€116,17420212022202320242025-€200,000-€100,000€0€100,000€200,000Operating result 2023: -€50,567-€50,600Net result 2023: -€123,374-€123,000Operating result 2024: €162,344€162,000Net result 2024: €107,359€107,000Operating result 2025: €152,640€153,000Net result 2025: €116,174€116,000202320242025
The operating result falls in 2025; 2025 is 6% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €230,568
Fixed assets €832 ▼ 46.6%
Current assets €229,735 ▲ 110%
Equity and liabilities €230,568
Equity €188,097 ▲ 83.2%
Debt €42,470 ▲ 407%
Debt's share of the balance-sheet total rises from 7.5% to 18.4%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€153,366▼
2024 · €163,406
Cash flow
€116,900▲
2024 · €108,421
Debt to equity
0.23▲
2024 · 0.08
ROE
61.8%▼
2024 · 104.6%
Interest coverage
164.48▲
2024 · 2.97
Debt ≤ 1 year
€42,071▲
2024 · €6,130
Income taxes
€36,460
Staff costs
€18,104▼
2024 · €18,320
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 26,970 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 95% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.5% went bankrupt
3.4% stopped otherwise
95% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 26,970 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet Code20242025
Assets
Total assets20/58€111,053€230,568▲
Fixed assets21/28€1,558€832▼
Tangible fixed assets22/27€1,188€462▼
Furniture and vehicles24€1,188€462▼
Financial fixed assets28€370€370=
Current assets29/58€109,495€229,735▲
Amounts receivable within one year40/41€198€39,000▲
Trade receivables40€198-
Other amounts receivable41-€39,000
Cash at bank and in hand54/58€87,413€169,735▲
Deferred charges and accrued income490/1€21,884€21,000▼
Equity and liabilities
Total equity and liabilities10/49€111,053€230,568▲
Equity10/15€102,673€188,097▲
Contributions10/11€18,600€18,600=
Reserves13€99,610€68,860▼
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Distributable reserves133€97,750€67,000▼
Profit (loss) carried forward14-€15,537€100,637▲
Amounts payable17/49€8,380€42,470▲
Amounts payable within one year42/48€6,130€42,071▲
Trade debts44€303€1,916▲
Suppliers440/4€303€1,916▲
Taxes, remuneration and social security45€3,671€40,155▲
Taxes450/3€330€36,896▲
Remuneration and social security454/9€3,341€3,259▼
Other amounts payable47/48€2,156-
Accrued charges and deferred income492/3€2,250€399▼
Income statement Code20242025
Remuneration, social security and pensions62€18,320€18,104▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,062€726▼
Other operating charges640/8€387€1,147▲
Non-recurring operating charges66A€833-
Gross operating margin9900€182,946€172,617▼
Operating profit (loss)9901€162,344€152,640▼
Financial income75/76B-€927
Recurring financial income75-€927
Financial charges65/66B€54,985€932▼
Recurring financial charges65€54,985€932▼
Profit (loss) for the period before taxes9903€107,359€152,635▲
Income taxes67/77-€36,460
Profit (loss) for the period9904€107,359€116,174▲
Profit (loss) for the period to be appropriated9905€107,359€116,174▲
Appropriation of the result
Profit (loss) to be appropriated9906-€15,537€100,637▲
Profit (loss) brought forward from the previous period14P-€122,896-€15,537▲
Transfer from equity791/2-€30,750
Profit to be distributed694/7-€30,750
Return on contributions (dividend)694-€30,750

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62--€15,848€18,320€18,104▼ 1.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€680€1,125€1,523€1,062€726▼ 31.7%
Other operating charges640/8€402€348€1,314€387€1,147▲ 196%
Non-recurring operating charges66A---€833--
Gross operating margin9900€75,354€111,049-€31,883€182,946€172,617▼ 5.6%
Operating profit (loss)9901€74,272€109,577-€50,567€162,344€152,640▼ 6.0%
Financial income75/76B€1,314€1,145--€927-
Recurring financial income75€1,314€1,145--€927-
Financial charges65/66B€75,577€58,886€72,807€54,985€932▼ 98.3%
Recurring financial charges65€75,577€58,886€72,807€54,985€932▼ 98.3%
Profit (loss) for the period before taxes9903€9€51,836-€123,374€107,359€152,635▲ 42.2%
Income taxes67/77€19€14,754--€36,460-
Profit (loss) for the period9904-€9€37,082-€123,374€107,359€116,174▲ 8.2%
Profit (loss) for the period to be appropriated9905-€9€37,082-€123,374€107,359€116,174▲ 8.2%
Line20212022202320242025Change
Assets
Total assets20/58€106,993€162,851€28,606€111,053€230,568▲ 108%
Fixed assets21/28€1,547€3,059€2,985€1,558€832▼ 46.6%
Tangible fixed assets22/27€1,476€2,988€2,615€1,188€462▼ 61.1%
Furniture and vehicles24€1,476€2,988€2,615€1,188€462▼ 61.1%
Financial fixed assets28€71€71€370€370€370=
Current assets29/58€105,447€159,792€25,621€109,495€229,735▲ 110%
Amounts receivable within one year40/41€19,652€28,233-€198€39,000▲ 19,597%
Trade receivables40---€198--
Other amounts receivable41€19,652€28,233--€39,000-
Cash at bank and in hand54/58€65,541€112,558€25,072€87,413€169,735▲ 94.2%
Deferred charges and accrued income490/1€20,253€19,000€549€21,884€21,000▼ 4.0%
Equity and liabilities
Total equity and liabilities10/49€106,993€162,851€28,606€111,053€230,568▲ 108%
Equity10/15€81,677€118,759-€4,686€102,673€188,097▲ 83.2%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Reserves13€62,610€99,610€99,610€99,610€68,860▼ 30.9%
Non-distributable reserves130/1€1,860€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860€1,860€1,860€1,860=
Distributable reserves133€60,750€97,750€97,750€97,750€67,000▼ 31.5%
Profit (loss) carried forward14€467€549-€122,896-€15,537€100,637▲ 748%
Amounts payable17/49€25,316€44,092€33,292€8,380€42,470▲ 407%
Amounts payable within one year42/48€22,896€28,198€31,292€6,130€42,071▲ 586%
Trade debts44€4,690€1,026€553€303€1,916▲ 533%
Suppliers440/4€4,690€1,026€553€303€1,916▲ 533%
Taxes, remuneration and social security45€19€27,172€18,839€3,671€40,155▲ 994%
Taxes450/3€19€27,172€14,966€330€36,896▲ 11,095%
Remuneration and social security454/9--€3,873€3,341€3,259▼ 2.5%
Other amounts payable47/48€18,187-€11,900€2,156--
Accrued charges and deferred income492/3€2,420€15,894€2,000€2,250€399▼ 82.3%
Line20212022202320242025Change
Profit (loss) for the period9904-€9€37,082-€123,374€107,359€116,174▲ 8.2%
+ Depreciation and write-downs630€680€1,125€1,523€1,062€726▼ 31.7%
Operating cash flow (approximation)€670€38,206-€121,852€108,421€116,900▲ 7.8%
Investment in fixed assets (approximation)--€2,637-€1,448€365€0▼ 100%
Change in cash-€47,017-€87,486€62,341€82,322▲ 32.1%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
19-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2018net €116,174 ▲8.2%
Net result €116,174, the highest in the series.
31-12
Financial Equity above €150,000Eq €188,097 ▲83.2%
2 profitable years in a row build equity to €188,097.
03-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Back to profitnet €107,359
Net result €107,359 after one loss-making year.
31-12
Financial Liquidity times 22current ratio 17.86
Current ratio from 0.82 to 17.86; short-term debt falls from €31,292 to €6,130.
31-12
Financial Equity above €100,000Eq €102,673
Equity rises from -€4,686 to €102,673.
25-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet -€123,374
Net result drops to -€123,374, the lowest in the series; recovery starts the following year.
22-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Back to profitnet €37,082
Net result €37,082 after one loss-making year.
31-12
Financial Equity above €100,000Eq €118,759 ▲45.4%
Equity rises from €81,677 to €118,759.
Show earlier events
06-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
09-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Liquidity quadruplescurrent ratio 7.42
Current ratio from 1.99 to 7.42; short-term debt falls from €45,518 to €12,888.
03-06
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
02-04
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2018
seat establishment The establishment unit on the map
Ground area
414 m²
Building footprint
294 m²
Volume, LiDAR
5,571 m³
Parcel 21618B0276/00X045, Brussels · tallest building 25.4 m, ±6 floors. Linked by address, not a title deed.
6 companies at this address See who is registered here
1 establishment unit
Winston Churchilllaan 3, 1180 Ukkel
Human health activities
since 20182.277.581.873
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21618B0276/00X045 Brussels 414 m² 1 · 294 m² 25.4 m · 6 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 1

According to the 2025 annual accounts of ALBECESA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Recognitions · licences · registrations

Legal Entity Identifier

2549000RO8A4ROSAE917
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 699 companies in sector 86910 we hold annual accounts for 522. 398 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded19-06-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.